Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), PACS Group Inc (PACS) and Universal Health (UHS)

Tipranks - Tipranks - Sat Feb 28, 7:33AM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tandem Diabetes Care (TNDM – Research Report), PACS Group Inc (PACS – Research Report) and Universal Health (UHS – Research Report).

Claim 50% Off TipRanks Premium

Tandem Diabetes Care (TNDM)

Citi analyst Joanne Wuensch maintained a Hold rating on Tandem Diabetes Care today. The company’s shares closed last Thursday at $25.79.

According to TipRanks.com, Wuensch is a 4-star analyst with an average return of 4.6% and a 58.0% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Establishment Labs Holdings, and Bausch + Lomb Corporation. ;'>

Currently, the analyst consensus on Tandem Diabetes Care is a Moderate Buy with an average price target of $29.80, implying a 14.7% upside from current levels. In a report issued on February 20, Bank of America Securities also upgraded the stock to Hold with a $30.00 price target.

See the top stocks recommended by analysts >>

PACS Group Inc (PACS)

Truist Financial analyst David S Macdonald reiterated a Buy rating on PACS Group Inc today and set a price target of $50.00. The company’s shares closed last Thursday at $41.67, close to its 52-week high of $43.92.

According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 11.5% and a 59.3% success rate. Macdonald covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Concentra Group Holdings Parent, Inc., and Ardent Health Partners, Inc. ;'>

PACS Group Inc has an analyst consensus of Strong Buy, with a price target consensus of $45.60, a 16.3% upside from current levels. In a report released today, TipRanks – PerPlexity also upgraded the stock to Buy with a $47.00 price target.

Universal Health (UHS)

TD Cowen analyst Ryan Langston maintained a Buy rating on Universal Health today and set a price target of $245.00. The company’s shares closed last Thursday at $204.33.

According to TipRanks.com, Langston ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -5.7% and a 39.8% success rate. Langston covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and Acadia Healthcare. ;'>

Universal Health has an analyst consensus of Moderate Buy, with a price target consensus of $257.43, representing a 17.3% upside. In a report issued on February 23, Guggenheim also maintained a Buy rating on the stock with a $274.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).